Humana Approved for $3.6 Million Research Funding Award by the Patient-Centered Outcomes Research Institute
July 12 2016 - 12:30PM
Business Wire
Research project will advance future health
care decision making
Humana Pharmacy Solutions’ health economics and outcomes
research subsidiary, Comprehensive Health Insights Inc., has been
approved for a $3.6 million funding award by the Patient-Centered
Outcomes Research Institute (PCORI).
The three-year project funded by the award creates a research
infrastructure linking Humana’s administrative claims database with
PCORI Clinical Data Research Networks to create “HUMnet” and
conduct research studies that add value and impact to PCORI.
The project is designed to show how health plans can partner
with PCORI Clinical Data Research Networks to capture de-identified
data, especially from claims and membership records. This is in
support of the network’s goal of speeding research that can help
patients and those who care for them make better-informed health
care decisions. To accomplish this, Comprehensive Health Insights
will utilize a Distributed Research Network approach based on a
Common Data Model. Click here to read more about the project.
Humana’s Comprehensive Health Insights, based in Louisville,
Ky., is comprised of more than 90 associates who conduct research
across three dimensions of customers: public, private and Humana.
The team focuses on treatment effectiveness, drug safety,
adherence, medical and pharmacy benefit design, disease management
programs, and other health care services.
“Humana is honored to be selected for this funding award as it
reflects our commitment to engage and work with organizations like
PCORI to improve the health of the nation,” said William Fleming,
president, Humana Pharmacy Solutions. “This is a very prestigious
award and reflects the strength of the research leaders inside
Humana’s Comprehensive Health Insights team.”
“This project was selected for PCORI funding not only for its
scientific merit and commitment to engaging patients and other
stakeholders, but also for its potential to fill an important gap
in our health knowledge and give people information to help them
weigh the effectiveness of their care options,” said PCORI
Executive Director Joe Selby, MD, MPH. “We look forward to
following the study’s progress and working with Humana’s
Comprehensive Health Insights to share the results.”
Humana’s Comprehensive Health Insights study was selected for
PCORI funding through a highly competitive review process in which
patients, clinicians, and other stakeholders joined clinical
scientists to evaluate the proposals. Applications were assessed
for scientific merit, how well they will engage patients and other
stakeholders, and their methodological rigor, among other
criteria.
Humana’s Comprehensive Health Insights’ award has been approved
pending completion of a business and programmatic review by PCORI
staff and issuance of a formal award contract.
PCORI is an independent, nonprofit organization authorized by
Congress in 2010. Its mission is to fund research that will provide
patients, their caregivers, and clinicians with the evidence-based
information needed to make better-informed healthcare decisions.
For more information about PCORI’s funding, visit
www.pcori.org.
PCORnet, the National Patient-Centered Clinical Research
Network, is an innovative initiative of PCORI that aims to improve
the nation’s capacity to conduct comparative clinical effectiveness
research efficiently by creating a large, highly representative
network for conducting clinical outcomes research that directly
involves patients in the development and execution of the
research.
About Humana Pharmacy
Solutions
Humana Pharmacy Solutions, a division of Humana Inc. (NYSE:
HUM), manages traditional pharmacy benefits with member-focused
strategies to yield savings in pharmacy and total health expense.
Providing prescription coverage for both individuals and employer
groups, Humana Pharmacy Solutions strives to give members access to
the medicine they need while offering guidance on clinically
proven, therapeutically equivalent drugs that bring better value to
the member and the customer. For more information visit
www.HumanaPharmacy.com.
About Humana
Humana Inc., headquartered in Louisville, Ky., is a leading
health and well-being company focused on making it easy for people
to achieve their best health with clinical excellence through
coordinated care. The company’s strategy integrates care delivery,
the member experience, and clinical and consumer insights to
encourage engagement, behavior change, proactive clinical outreach
and wellness for the millions of people we serve across the
country.
More information regarding Humana is available to investors via
the Investor Relations page of the company’s web site at
www.humana.com, including copies of:
- Annual reports to stockholders
- Securities and Exchange Commission
filings
- Most recent investor conference
presentations
- Quarterly earnings news releases
- Replays of most recent earnings release
conference calls
- Calendar of events
- Corporate Governance information
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160712006459/en/
Humana Inc.Corporate Communications:Marina Renneke,
602-760-1758mrenneke@humana.com
Humana (NYSE:HUM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Humana (NYSE:HUM)
Historical Stock Chart
From Jul 2023 to Jul 2024